TDACU

Translational Development Acquisition Corp. Units

TDACU
Closed
$11.98
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has neither engaged in any operations nor generated any revenues.
Country

US

CEO

Mr. Michael Hoffman

IPO date

2024

Employees

0

ISIN

KYG9008W1050

Website

-

Key stats

Open

$11.95

Volume

588.00

Market cap

$234.41M

Prev. close

$11.98

Impl / hst vl

-

Open interest

$0.00

$11.95

Day’s Range

$11.98

$10.44

52W Range

$17.29

Valuation

33
Valuation score
Overvalued
P/E
37.73
P/S
-
P/B
1.33
Current ratio
0.09
Debt / Equity
-
ROE
3.57%
Gross margin
-
Income growth
-16.49%
FCF growth
159.97

Analysts estimates

Avg. price target
$20.33
The top 3 analysts forecasts that 12-month price may increase by 69.72%, with a low of $20.13 and a high of $20.93
$20.13
Low
$20.33
Avg
$20.93
High
Current price

Earnings

Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
$1.33M
Revenue
Net income
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply